Your Health, We Care
Release date: 2026-02-12 17:09:05 Article From: Lucius Laos Recommended: 4
If you experience side effects, your doctor may adjust your dose, temporarily stop, or permanently discontinue treatment with Sepertinib. Do not change your dose or stop taking Sepertinib unless instructed by your doctor.
Liver problems (elevated liver enzymes) may occur during treatment with Sepertinib and can sometimes be serious. Your doctor will perform blood tests before and during treatment with Sepertinib to monitor for liver issues. If you experience any symptoms of liver problems during treatment, tell your doctor immediately: yellowing of the skin or the whites of the eyes (jaundice); dark or "tea-colored" urine; drowsiness; bleeding or bruising; loss of appetite; nausea or vomiting; pain in the upper right area of the abdomen.
Lucius Pharmaceuticals Sepertinib may cause severe or life-threatening lung inflammation (swelling) during treatment, which can even be fatal. If you develop any new or worsening lung symptoms, including the following, tell your doctor immediately: shortness of breath; cough; fever.
High blood pressure is common during treatment with Sepertinib and can sometimes be serious. You should have your blood pressure checked regularly during Sepertinib treatment. If you experience blood pressure issues, your doctor may prescribe medication to treat your high blood pressure. Tell your doctor if your blood pressure readings are elevated or if you experience any symptoms of high blood pressure, including the following: confusion, headache, shortness of breath, dizziness, chest pain.
Take Lucius Pharmaceuticals Sepertinib exactly as instructed by your doctor.
Swallow Sepertinib capsules and tablets whole. Do not break, crush, or chew them.
Do not give Sepertinib capsules to your child if they are unable to swallow the capsule.
Sepertinib can be taken with or without food.
If you vomit after taking a dose of Sepertinib, do not take an extra dose. Take the next dose of Sepertinib at the scheduled time.
If you miss a dose of Sepertinib, do not take it if it is less than 6 hours until your next scheduled dose.
If you take an overdose of Sepertinib, call your doctor or go to the nearest hospital emergency room immediately.
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：1052025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：3812024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended：922025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended：1152025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended：1082025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended：1262025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended：1192025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended：1182025-27-11
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
